Agenus reported 60219000 in Operating Expenses for its second fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie U$ 9673M 4657M
Acceleron Pharma 58665000 2749000
Agenus 6021900 1490700
Amgen 388300000 7700000
AstraZeneca 499100000 14300000
Bristol Myers Squibb 918700000 71300000
Celldex Therapeutics 11601000 3994000
CSL 315570000 12280000
Dicerna Pharmaceuticals 73941000 14747000
Dynavax Technologies 26007000 4224000
Eli Lilly And U$ 4302.6M 33.6M
Genocea Biosciences 1206700 130800
Gilead Sciences U$ 8126M 4980M
GlaxoSmithKline 477400000 230200000
Glaxosmithkline 6788000000 2014000000
Immunogen 3338700 371000
Intrexon U$ 69M 14M
Johnson & Johnson 1668100000 228500000
Macrogenics 67567000 8440000
Merck 362800000 2600000
Merk U$ 7743M 405M
Novartis 9270000000 694000000
Novavax 52565000 26291000
Pfizer U$ 8360M 920M
Regeneron Pharmaceuticals U$ 1295.6M 167.5M
Stemline Therapeutics 30725680 549440
Veracyte 3175500 1156700
YTE 45727000 77524100